Reduced ligand affinity leads to an impaired function of the adenosine A2A receptor of human granulocytes in sepsis

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 5, 2009, Pages 985-994

  Kreth, Simone ^a   Kaufmann, Ines ^a   Ledderose, Carola ^a   Luchting, Benjamin ^a   Thiel, Manfred ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

A2A receptor; Human PMN; Ligand affinity; Sepsis

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; ADENYLATE CYCLASE; CYTOKINE; ISOPROTEIN; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; HUMAN; METABOLISM; NEUTROPHIL; PHYSIOLOGY; SEPSIS;

ADENOSINE; ADENYLATE CYCLASE; CELLS, CULTURED; CYTOKINES; HUMANS; LIPOPOLYSACCHARIDES; NEUTROPHILS; PROTEIN ISOFORMS; REACTIVE OXYGEN SPECIES; RECEPTOR, ADENOSINE A2A; SEPSIS;

EID: 67249089932     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00530.x     Document Type: Article

References (47)

1. Peters K, Unger RE, Brunner J, Kirkpatrick CJ. Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res. 2003 60 : 49 57. (Pubitemid 38373475)
2. Cohen J. The immunopathogenesis of sepsis. Nature. 2002 420 : 885 91.
3. Hoesel LM, Neff TA, Neff SB, Younger JG, Olle EW, Gao H Pianko MJ, Bernacki KD, Sarma JV, Ward PA. Harmful and protective roles of neutrophils in sepsis. Shock. 2005 24 : 40 7.
4. Martins PS, Kallas EG, Neto MC, Dalboni MA, Blecher S, Salomao R. Upregulation of reactive oxygen species generation and phagocytosis, and increased apoptosis in human neutrophils during severe sepsis and septic shock. Shock. 2003 20 : 208 12.
5. Kaufmann I, Hoelzl A, Schliephake F, Hummel T, Chouker A, Peter K, Thiel M. Polymorphonuclear leukocyte dysfunction syndrome in patients with increasing sepsis severity. Shock. 2006 26 : 254 61.
6. Cronstein BN, Levin RI, Belanoff J, Weissman G, Hirschhorn R. Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells. J Clin Invest. 1986 78 : 760 70.
7. Latini S, Bordoni F, Pedata F, Corradetti R. Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices. Br J Pharmacol. 1999 127 : 729 39.
8. Kaufmann I, Hoelzl A, Schliephake F, Hummel T, Chouker A, Lysenko L, Thiel M. Effects of adenosine on functions of polymorphonuclear leukocytes from patients with septic shock. Shock. 2007 27 : 25 31. (Pubitemid 44968006)
9. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev. 2001 53 : 527 52.
10. Sitkovsky MV, Ohta A. The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol. 2005 26 : 299 304. (Pubitemid 40732662)
11. Linden J. New insights into the regulation of inflammation by adenosine. J Clin Invest. 2006 116 : 1835 7.
12. Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M Jones MR, St Hilaire C, Seldin DC, Toselli P, Lamperti E, Schreiber BM, Gavras H, Wagner DD, Ravid K. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest. 2006 116 : 1913 23.
13. Kreth S, Ledderose C, Kaufmann I, Groeger G, Thiel M. Differential expression of 5′-UTR splice variants of the adenosine A2A receptor gene in human granulocytes: identification, characterization, and functional impact on activation. FASEB J. 2008 22 : 3276 86.
14. Fortin A, Harbour D, Fernandes M, Borgeat P, Bourgoin S. Differential expression of adenosine receptors in human neu-trophils: up-regulation by specific Th1 cytokines and lipopolysaccharide. J Leukoc Biol. 2006 79 : 574 85.
15. Varani K, Laghi-Pasini F, Camurri A, Capecchi PL, Maccherini M, Diciolla F Ceccatelli L, Lazzerini PE, Ulouglu C, Cattabeni F, Borea PA, Abbracchio MP. Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation. FASEB J. 2003 17 : 280 2.
16. Németh ZH, Csdka B, Wilmanski J, Xu D, Lu Q, Ledent C, Deitch EA, Pacher P, Spolarics Z, Haskd G. Adenosine A2A receptor inactivation increases survival in polymicrobial sepsis. J Immunol. 2006 176 : 5616 26.
17. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature. 2001 414 : 916 20.
18. Bone RC, Balk A, Cerra FB, Dellinger R P, Fein AM, Knaus WA Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP-SCCM Consensus Conference Committee. American College of Chest Physicians-Society of Critical Care Medicine. Chest. 1992 101 : 1644 55.
19. Thiel M, Imendorffer S, Chouker A, Groh J, Briegel J, Anthuber M, Kramling HJ, Arfors KE, Peter K, Messmer K. Expression of adhesion molecules on circulating polymorphonuclear leukocytes during orthotopic liver transplantation. Hepatology. 1998 28 : 1538 50.
20. Haskó G, Cronstein BN. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 2004 25 : 33 9.
21. Sitkovsky MV, Lukashev D, Apasov S, Kojima H, Koshiba M, Caldwell C, Ohta A, Thiel M. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A(2A) receptors. Annu Rev Immun. 2004 22 : 657 82.
22. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol. 2001 1 : 135 45.
23. Janssens S, Beyaert R. Role of toll-like receptors in pathogen recognition. Clin Microbiol Rev. 2003 16 : 637 46.
24. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal. 2001 13 : 85 94. (Pubitemid 32222977)
25. Liu SF, Ye X, Malik AB. In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol. 1997 159 : 3976 83.
26. Liu SF, Ye X, Malik AB. Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate in vivo prevents expression of proinflammatory genes. Circulation. 1999 100 : 1330 7.
27. Thiel M, Chouker A. Acting via A2 receptors, adenosine inhibits the production of tumor necrosis factor-alpha of endotoxin-stimulated human polymorphonuclear leukocytes. J Lab Clin Med. 1995 126 : 275 82.
28. Peula-GarcÌa JM, Molina-Bolivar JA, Velasco J, Rojas A, Galisteo-González F. Interaction of bacterial endotoxine (lipopolysaccharide) with latex particles: application to latex agglutination immunoassays. J Colloid Interface Sci. 2002 245 : 230 6.
29. Hurley JC. Endotoxemia: methods of detection and clinical correlates. Clin Microbiol Rev. 1995 8 : 268 92.
30. Brandtzaeg P, Ovstebøo R, Kierulf P. Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease. J Infect Dis. 1992 166 : 650 2.
31. Khoa ND, Montesinos MC, Reiss AB, Delano D, Awadallah N, Cronstein BN. Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells. J Immunol. 2001 167 : 4026 32.
32. Khoa ND, Montesinos MC, Williams AJ, Kelly M, Cronstein BN. Th1 cytokines regulate adenosine receptors and their downstream signaling elements in human microvascular endothelial cells. J Immunol. 2003 171 : 3991 8.
33. Khoa ND, Postow M, Danielsson J, Cronstein BN. Tumor necrosis factor-alpha prevents desensitization of Galphas-coupled receptors by regulating GRK2 association with the plasma membrane. Mol Pharmacol. 2006 69 : 1311 9.
34. McColl SR, St Onge M, Dussault AA, Laflamme C, Bouchard L, Boulanger J, Pouliot M. Immunomodulatory impact of the A2A adenosine receptor on the profile of chemokines produced by neutrophils. FASEB J. 2006 20 : 187 9.
35. Kirkpatrick P. G-protein coupled receptors: putting the brake on inflammation. Nat Rev Drug Discov. 2002 1 : 99.
36. Klaasse EC, IJzerman AP, De Grip WJ, Beukers MW. Internalization and desensitization of adenosine receptors. Purinergic Signalling. 2008 4 : 21 37.
37. Kelly E, Bailey C P, Henderson G. Agonist-selective mechanisms of GPCR desensitization. Br J Pharmacol. 2008 153 : 379 88.
38. Varani K, Gessi S, Merighi S, Iannotta V, Cattabriga E, Spisani S, Cadossi R, Borea PA. Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. Br J Pharmacol. 2002 136 : 57 66. (Pubitemid 34499316)
39. Varani K, Portaluppi F, Gessi S, Merighi S, Vincenzi F, Cattabriga E, Dalpiaz A, Bortolotti F, Belardinelli L, Borea PA. Caffeine intake induces an alteration in human neutrophil A2A adenosine receptors. Cell Mol Life Sci. 2005 62 : 2350 8.
40. Rovati GE. Ligand-binding studies: old beliefs and new strategies. Trends Pharmacol Sci. 1998 19 : 365 9.
41. Pierce KD, Furlong TJ, Selbie LA, Shine J. Molecular cloning and expression of an adenosine A2b receptor from human brain. Biochem Biophys Res Commun. 1992 187 : 86 93.
42. Gilchrist A. Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics. Trends Pharmacol Sci. 2007 28 : 431 7.
43. Zezula J, Freissmuth M. The A2A-adenosine receptor: a GPCR with unique features? Br J Pharmacol. 2008 153 : 184 90.
44. May LT, Leach K, Sexton PM, Christopoulos A. Allosteric modulation of G protein-coupled receptors. Annu Rev Pharmacol Toxicol. 2007 47 : 1 51. (Pubitemid 46277033)
45. Gao ZG, Ijzerman AP. Allosteric modulation of A(2A) adenosine receptors by amiloride analogues and sodium ions. Biochem Pharmacol. 2000 60 : 669 76.
46. Hillion J, Canals M, Torvinen M, Casado V, Scott R, Terasmaa A Hansson A, Watson S, Olah ME, Mallol J, Canela EI, Zoli M, Agnati LF, Ibanez CF, Lluis C, Franco R, Ferre S, Fuxe K. Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J Biol Chem. 2002 277 : 18091 7.
47. Christopoulos A, Kenakin T. G protein-coupled receptor allosterism and complexing. Pharmacol Rev. 2002 54 : 323 74.